Atlantic Health Strategies

Behavioral Health M&A, the Paused 2024 Parity Rule, and DOJ’s Record 2025 Takedown: What Treatment Center Operators Should Actually Do

Table of Contents

Ready to See Results?

From strategy through execution, Atlantic Health Strategies integrates compliance, operations, and growth into durable, measurable results. Let’s put our expertise to work for your organization.

The short answer for operators heading into 2026

Buyers are back, the federal parity rule is on ice, and the Department of Justice just posted its largest healthcare fraud enforcement year on record. If you run a treatment center, do not slow down. Tighten your compliance file, document your NQTL analyses under the 2013 rule that is still in force, and prepare diligence materials that assume a data-driven regulator is already looking at your billing patterns.

Three things happened between late 2024 and mid-2025 that reshape how founders, COOs, and PE-backed buyers should think about the next 18 months. Federal regulators paused enforcement of the September 2024 Mental Health Parity and Addiction Equity Act Final Rule. DOJ charged 324 defendants in a single coordinated action tied to over $14.6 billion in intended losses, with behavioral health cases prominently featured. And behavioral health M&A deal volume climbed sharply, with aggregate deal flow up 17% year over year and a record 31 IDD transactions. Read those three together and the operator playbook writes itself.

What actually happened with the 2024 Parity Rule

On September 23, 2024, the Departments of Labor, Health and Human Services, and Treasury published a Final Rule implementing changes to MHPAEA. It required plans to prepare comparative analyses of non-quantitative treatment limitations, imposed a fiduciary certification duty on ERISA plans, and layered on a “meaningful benefits” standard plus outcomes testing. Documentation rules were slated to hit plan years starting January 1, 2025. Meaningful benefits and outcomes testing were set for January 1, 2026.

Then the ERISA Industry Committee sued. ERIC filed its complaint on January 17, 2025 in the U.S. District Court for the District of Columbia, alleging the rule exceeded statutory authority, violated the Administrative Procedure Act, and improperly delegated regulatory power. On May 9, 2025, the Departments asked the court to hold the case in abeyance while they reconsidered the rule. The court granted the abeyance on May 12, 2025.

Three days later, the tri-agencies published a joint statement. In the words of the Departments themselves: “The Departments will not enforce the 2024 Final Rule or otherwise pursue enforcement actions, based on a failure to comply that occurs prior to a final decision in the litigation, plus an additional 18 months.” That is the pause. It is real, and it is long.

Here is what the pause does not do. It does not repeal MHPAEA. It does not eliminate the 2013 final regulations. It does not remove the statutory NQTL comparative analysis requirement imposed by the Consolidated Appropriations Act of 2021. As the DOL statement puts it plainly, “MHPAEA’s statutory obligations, as amended by the CAA, 2021, continue to have effect.” Private plaintiffs can also still sue under ERISA. Buyers will still ask for your NQTL file during diligence. Commercial payers are still running utilization management under the 2013 framework. Get it done.

DOJ 2025: the largest healthcare fraud takedown ever, and behavioral health was in the crosshairs

On June 30, 2025, DOJ announced charges against 324 defendants, including 96 doctors, nurse practitioners, pharmacists, and other licensed medical professionals, across 50 federal districts and 12 State Attorneys General’s Offices, involving over $14.6 billion in intended loss. HHS-OIG confirmed it was the largest healthcare fraud takedown in DOJ history, doubling the prior $6 billion record. The government seized over $245 million in cash, luxury vehicles, cryptocurrency, and other assets.

Behavioral health was not a footnote. In the District of Arizona, prosecutors charged Farrukh Jarar Ali with an alleged $650 million scheme involving at least 41 substance abuse treatment clinics that billed AHCCCS for services that were not provided, not provided as billed, or medically unnecessary. AHCCCS paid approximately $564 million on those claims, and many patients were recruited from homeless populations or Native American reservations. Attorney General Pamela Bondi framed the enforcement posture directly: “This record-setting Health Care Fraud Takedown delivers justice to criminal actors who prey upon our most vulnerable citizens and steal from hardworking American taxpayers.”

The mechanics matter as much as the numbers. CMS also prevented over $4 billion from being paid on false and fraudulent claims and suspended or revoked the billing privileges of 205 providers in the months leading up to the Takedown. DOJ built its new Data Fusion Center with HHS-OIG, the FBI, DEA, and CMS. That is the speed operators should assume.

M&A is heating up, and buyers are pricing compliance

The market is not waiting for perfect visibility. Dexter Braff of The Braff Group told Behavioral Health Business that when you drill down, “Q1 was a great quarter as well, up 53% vs. Q4 2024 and the second highest output since Q1 of 2022,” with mental health alone stacking 19 deals in the first quarter. Braff’s year-end update pegged aggregate behavioral health deal flow in 2025 up 17% over the prior year, the second consecutive year of gains over 2023. The IDD sector topped its record with 31 deals in 2025, one more than its prior high of 30 in 2021, while mental health closed more than 80 deals compared with about 70 in 2024.

Translate that for a founder considering an exit or a PE sponsor sizing a bolt-on. Buyers pay for platforms that show clean licensure across states, current accreditation with no probational history, documented NQTL responses on file with commercial payers, and a billing profile that does not look like an outlier when someone at the Data Fusion Center runs a query. Sponsors have started walking away from targets where diligence turns up SIU audit letters, unresolved payer takebacks, or utilization management practices that cannot be defended in writing. I watched a Florida deal die in Q3 over an unresolved managed-care recoupment demand under $400,000. The number was small. The signal was not.

One caveat worth flagging. SUD deals fell to 12 in 2025 from 16 in 2024, and Braff expects a smaller, more selective buyer cohort going forward. Founders in substance use treatment do not get to coast on sector tailwinds; buyers who show up are picky.

What treatment center operators should actually do in the next 90 days

Operators keep asking me whether the parity pause means they can loosen up. My answer is no. As the International Foundation of Employee Benefit Plans put it, “Plan sponsors are required to follow the law even though regulations aren’t being enforced.” Commercial payers are still running utilization management under the 2013 framework. Plaintiffs can still sue. Buyers will still ask for your NQTL file during diligence.

  1. Complete or refresh your NQTL comparative analysis under the 2013 rule and the CAA 2021. If you contract with commercial plans, request the plan’s analysis when a level-of-care denial comes through. Under CAA 2021, plans must produce it.
  2. Run a mock survey against your current licensure and accreditation body (CARF, Joint Commission, COA). Focus your surveyors on medication management, ASAM Criteria 4th Edition level-of-care determinations, EOC tour readiness, and personnel files. A three-year accreditation with zero conditions is a diligence asset. A one-year conditional accreditation is a valuation hit.
  3. Pull a 12-month billing self-audit. Look at units per patient per day, group vs. Individual mix, telehealth utilization, and any code that sits meaningfully above peer benchmarks. If your PHP (ASAM Level 2.5, an outpatient level of care) or residential withdrawal management billing patterns look unusual, an auditor at CMS or a state MFCU will see it before you do.
  4. Tighten your terminations-and-access workflow. Auditors will ask how quickly terminated staff lose EMR access, whether your system logs failed logins, and how you reconcile documented service hours against payroll.
  5. Build your data room before you need it. Founders who wait until a signed LOI to organize licensure, accreditation, payer contracts, credentialing files, and compliance policies lose 60 to 90 days on the timeline and often see a retrade. Buyers reward operators who can produce a clean file in a week.

The pause on the 2024 Final Rule is a gift of runway, not a reprieve. Operators who use it to build the operational backbone their buyers, payers, and regulators will demand come out of 2026 in a materially stronger position. Everyone else finds out the hard way.

Frequently asked questions

Is the 2024 MHPAEA Final Rule still in effect for behavioral health providers?

No. On May 15, 2025, the Departments of Labor, HHS, and Treasury announced they will not enforce the 2024 Final Rule until a final decision in the ERIC v. HHS litigation, plus an additional 18 months. However, the 2013 MHPAEA regulations and the CAA 2021 statutory requirement to maintain a written NQTL comparative analysis remain fully in force, and private plaintiffs may still bring MHPAEA claims under ERISA. Providers should continue to document parity compliance and request payer analyses when medical-necessity denials occur.

How large was the DOJ 2025 National Health Care Fraud Takedown, and what does it mean for behavioral health operators?

DOJ announced criminal charges against 324 defendants across 50 federal districts involving over $14.6 billion in intended loss on June 30, 2025, the largest healthcare fraud takedown in department history and more than double the prior $6 billion record. CMS also prevented more than $4 billion in fraudulent payments and revoked or suspended 205 providers’ billing privileges in the months prior. Behavioral health cases were prominent, including a $650 million Arizona AHCCCS SUD scheme involving 41 substance abuse treatment clinics.

What is the state of behavioral health M&A heading into 2026?

Deal volume accelerated through 2025. The Braff Group reported Q1 2025 behavioral health deal volume up 53% versus Q4 2024, and aggregate 2025 behavioral health deal flow up 17% year over year, the second consecutive annual gain. Mental health closed more than 80 deals and IDD hit a record 31 transactions in 2025. Buyers are paying premiums for multi-state platforms with clean accreditation, diversified payer contracts, and defensible utilization management practices.

What should a treatment center operator do first if they expect to sell or take on private equity in the next 12 to 18 months?

Start with a mock survey against your current accreditation body, complete or refresh your NQTL comparative analysis under the 2013 rule and CAA 2021, and run a 12-month billing self-audit that benchmarks your units-per-patient-per-day and level-of-care mix against peers. Then organize a diligence-ready data room covering licensure across every state you operate in, accreditation history with no unresolved conditions, payer contracts, credentialing files, and compliance policies. Buyers who see a clean file move faster and retrade less.

Request a Free Consultation

Scroll to Top